Celine I. Busard

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Quantifying the Effect of Methotrexate on Adalimumab Response in Psoriasis by Pharmacokinetic-Pharmacodynamic Modeling.

Quantifying the Effect of Methotrexate on Adalimumab Response in Psoriasis by Pharmacokinetic-Pharmacodynamic Modeling.

Journal: The Journal of investigative dermatology
Published: January 21, 2023

Adalimumab combined with methotrexate versus adalimumab monotherapy in psoriasis: Three-year follow-up data of a single-blind randomized controlled trial.

Adalimumab combined with methotrexate versus adalimumab monotherapy in psoriasis: Three-year follow-up data of a single-blind randomized controlled trial.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: November 17, 2022

Adalimumab with Methotrexate vs. Adalimumab Monotherapy in Psoriasis: First-Year Results of a Single-Blind Randomized Controlled Trial.

Adalimumab with Methotrexate vs. Adalimumab Monotherapy in Psoriasis: First-Year Results of a Single-Blind Randomized Controlled Trial.

Journal: The Journal of investigative dermatology
Published: February 04, 2020

Clinical Consequences of Antibody Formation, Serum Concentrations, and HLA-Cw6 Status in Psoriasis Patients on Ustekinumab.

Clinical Consequences of Antibody Formation, Serum Concentrations, and HLA-Cw6 Status in Psoriasis Patients on Ustekinumab.

Journal: Therapeutic drug monitoring
Published: May 21, 2019

Highlights of the updated Dutch evidence- and consensus-based guideline on psoriasis 2017.

Highlights of the updated Dutch evidence- and consensus-based guideline on psoriasis 2017.

Journal: The British journal of dermatology
Published: September 02, 2018

Core outcome sets in dermatology: report from the second meeting of the International Cochrane Skin Group Core Outcome Set Initiative.

Core outcome sets in dermatology: report from the second meeting of the International Cochrane Skin Group Core Outcome Set Initiative.

Journal: The British journal of dermatology
Published: October 16, 2017

Reporting of outcomes in randomized controlled trials on nail psoriasis: a systematic review.

Reporting of outcomes in randomized controlled trials on nail psoriasis: a systematic review.

Journal: The British journal of dermatology
Published: July 14, 2017

Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries.

Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: April 27, 2017

Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial.

Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial.

Journal: Trials
Published: February 17, 2017

Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial.

Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial.

Journal: Trials
Published: July 26, 2016

Combined use of systemic agents for psoriasis: a systematic review.

Combined use of systemic agents for psoriasis: a systematic review.

Journal: JAMA dermatology
Published: September 05, 2014
Showing 1-11 of 11

Last Updated: 09/26/2026